Annual Operating Expenses
$69.90 M
+$295.50 K+0.42%
31 December 2023
Summary:
Innate Pharma SA annual total operating expenses is currently $69.90 million, with the most recent change of +$295.50 thousand (+0.42%) on 31 December 2023. During the last 3 years, it has fallen by -$1.01 million (-1.43%). IPHA annual operating expenses is now -20.44% below its all-time high of $87.86 million, reached on 31 December 2018.IPHA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
N/A
30 June 2024
Summary:
Innate Pharma SA quarterly total operating expenses is not available.IPHA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPHA Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -1.4% | - |
| 5 y5 years | -6.8% | - |
IPHA Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.4% | +0.4% | ||
| 5 y | 5 years | -6.8% | +11.1% | ||
| alltime | all time | -20.4% | +690.0% |
Innate Pharma SA Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $69.90 M(+0.4%) | - |
| Dec 2022 | $69.61 M(-1.8%) | - |
| Dec 2021 | $70.92 M(+12.7%) | - |
| Apr 2021 | - | $49.28 M(+3.8%) |
| Jan 2021 | - | $47.50 M(+2.2%) |
| Dec 2020 | $62.90 M(-16.2%) | - |
| Oct 2020 | - | $46.46 M(-8.1%) |
| July 2020 | - | $50.55 M(-3.4%) |
| Apr 2020 | - | $52.34 M(+7.1%) |
| Jan 2020 | - | $48.88 M(-4.5%) |
| Dec 2019 | $75.05 M(-14.6%) | - |
| Oct 2019 | - | $51.17 M(-1.6%) |
| July 2019 | - | $52.00 M(+2.3%) |
| Apr 2019 | - | $50.82 M(+2.6%) |
| Jan 2019 | - | $49.53 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $87.86 M(+159.7%) | - |
| Oct 2018 | - | $51.37 M(-2.5%) |
| July 2018 | - | $52.69 M |
| Dec 2017 | $33.83 M(-37.1%) | - |
| Dec 2016 | $53.78 M(+69.0%) | - |
| Dec 2015 | $31.83 M(+14.6%) | - |
| Dec 2014 | $27.76 M(+172.8%) | - |
| Dec 2013 | $10.18 M(+15.0%) | - |
| Dec 2012 | $8.85 M(-9.3%) | - |
| Dec 2011 | $9.75 M(-49.5%) | - |
| Dec 2010 | $19.33 M(-30.4%) | - |
| Dec 2009 | $27.76 M(-7.7%) | - |
| Dec 2008 | $30.07 M(+6.4%) | - |
| Dec 2007 | $28.26 M(+66.4%) | - |
| Dec 2006 | $16.98 M(+72.4%) | - |
| Dec 2005 | $9.85 M | - |
FAQ
- What is Innate Pharma SA annual total operating expenses?
- What is the all time high annual operating expenses for Innate Pharma SA?
- What is the all time high quarterly operating expenses for Innate Pharma SA?
What is Innate Pharma SA annual total operating expenses?
The current annual operating expenses of IPHA is $69.90 M
What is the all time high annual operating expenses for Innate Pharma SA?
Innate Pharma SA all-time high annual total operating expenses is $87.86 M
What is the all time high quarterly operating expenses for Innate Pharma SA?
Innate Pharma SA all-time high quarterly total operating expenses is $52.69 M